Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast
Journal of Investigative Dermatology · 2024
DOI: 10.1016/j.jid.2024.01.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2024. Verfasst von Emma L Larson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA; Department of Dermatology, University Hospitals Cleveland Medical C…. Hauptthemen laut MEDLINE: Thalidomide, Psoriasis, Monocytes, Phosphodiesterase 4 Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institutes of Health, Amgen Inc.
Abstract (Originalsprache)
Monocytes play a critical role in the inflammation associated with psoriasis, and their abnormalities have been reported as biomarkers of cardiovascular event risk, a psoriasis comorbidity. Monocytic cells in chronic inflammatory disorders express elevated levels of cAMP phosphodiesterase. Restoring cAMP levels using the oral cAMP phosphodiesterase-4 inhibitor, apremilast, improves clinical outcomes for a subset of patients with psoriasis. We asked whether aberrant monocyte subsets or transcriptomic pathways can function as biomarkers of psoriasis endotypes that can predict enhanced clinical responses to cAMP phosphodiesterase inhibition. A 16-week open-label study of 22 patients with monocyte flow cytometric and transcriptomic analysis was performed. Subjects with elevated hyperadhesive monocyte doublets at baseline were more likely to be responders to apremilast (P < .0001); 82% of subjects with elevated hyperadhesive monocyte doublets achieved 50% reduction in PASI compared with 46% in those without elevated doublets. We observed a significant reduction in hyperadhesive monocyte-containing doublets and monocyte-platelet aggregates, suggesting an effect of apremilast on the adhesiveness of blood monocytes during chronic inflammation. Monocyte differentially expressed gene transcripts predictive of clinical response uncovered pharmacoendotypes with distinct patterns of nucleotide metabolism, energetics, and differentiation. Further study to understand the basis of drug responsiveness and to develop an apremilast psoriasis treatment algorithm using monocyte-refined gene expression is required to validate and become practical in clinical use, offering patients a test that personalizes their likelihood of clinical response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA; Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. Electronic address: Emma.Larson@UHhospita…
- Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA; Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton Ohio, Ohio, USA.
Förderung
- NIAMS NIH HHS
- National Institutes of Health
- Amgen Inc
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Larson, E. L., DeMeo, D. P., Young, A. B., Margevicius, S., Rutter, J., Davies, A. L., Rohan, C. A., Korman, N. J., Travers, J. B., McCormick, T. S., & Cooper, K. D. (2024). Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2024.01.034
Vancouver
Larson EL, DeMeo DP, Young AB, Margevicius S, Rutter J, Davies AL, et al. Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast. Journal of Investigative Dermatology. 2024. doi:10.1016/j.jid.2024.01.034
BibTeX
@article{Larson2024,
author = {Larson, Emma L and DeMeo, Dustin P and Young, Andrew B and Margevicius, Seunghee and Rutter, Joseph and Davies, Amanda L and Rohan, Craig A and Korman, Neil J and Travers, Jeffrey B and McCormick, Thomas S and Cooper, Kevin D},
title = {Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast},
journal = {Journal of Investigative Dermatology},
year = {2024},
doi = {10.1016/j.jid.2024.01.034}
}
EUVIMED